128 related articles for article (PubMed ID: 24632007)
1. Response to Dr Bredemeier's letter.
Vital EM; Dass S; Buch MH; Rawstron AC; Emery P
Ann Rheum Dis; 2014 Jun; 73(6):e34. PubMed ID: 24632007
[No Abstract] [Full Text] [Related]
2. Is an extra dose of rituximab an efficacious and safe alternative to improve outcomes in rheumatoid arthritis? Comment on the article by Vital et al.
Bredemeier M
Ann Rheum Dis; 2014 Jun; 73(6):e33. PubMed ID: 24595549
[No Abstract] [Full Text] [Related]
3. Can response duration after the first rituximab treatment be used in timing of rituximab retreatment?
van Herwaarden N; van der Maas A; Jansen TL; Dutmer EA; Hartkamp A; van Riel PL; Kievit W; van den Bemt BJ; den Broeder AA
Scand J Rheumatol; 2013; 42(3):251-2. PubMed ID: 23496283
[No Abstract] [Full Text] [Related]
4. [Rituximab: Half dose with full strength?].
Feist E
Z Rheumatol; 2014 Nov; 73(9):856-7. PubMed ID: 24942603
[No Abstract] [Full Text] [Related]
5. More or less rituximab? Biology and clinic, regulators and researchers.
van Vollenhoven RF
Arthritis Rheum; 2011 Mar; 63(3):594-6. PubMed ID: 21360487
[No Abstract] [Full Text] [Related]
6. Choosing the right rituximab dose for the right patient: comment on the article by Bredemeier et al.
Vital EM; Md Yusof MY; Emery P
Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1591-3. PubMed ID: 24905770
[No Abstract] [Full Text] [Related]
7. Comment on: Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR).
Conway R; Carey JJ
Rheumatology (Oxford); 2011 Mar; 50(3):631-2; author reply 632-3. PubMed ID: 21172927
[No Abstract] [Full Text] [Related]
8. Prompt efficacy of very low-dose rituximab on monoclonal B lymphocytosis in a rheumatoid arthritis patient.
Bruzzese V; Marrese C; Hassan C; Andriani A; Zullo A
Int J Rheum Dis; 2013 Dec; 16(6):764-5. PubMed ID: 24200218
[No Abstract] [Full Text] [Related]
9. Biological treatment of rheumatoid arthritis: towards a more cost-effective re-treatment regimen using rituximab?
Boumans MJ; Vos K; Gerlag DM; Tak PP
Ann Rheum Dis; 2012 Mar; 71(3):472-3. PubMed ID: 21908451
[No Abstract] [Full Text] [Related]
10. [Recommendations for use of rituximab in patients with rheumatoid arthritis].
Rubbert-Roth A; Burmester GR; Dörner T; Gause A;
Z Rheumatol; 2014 Mar; 73(2):165-74. PubMed ID: 24659153
[TBL] [Abstract][Full Text] [Related]
11. Severe Pasteurella multocida infection in a patient on rituximab therapy for rheumatoid arthritis.
Rouil A; Pollet S; Martin A; Tattevin P; Perdriger A
Joint Bone Spine; 2013 Mar; 80(2):224-5. PubMed ID: 23477740
[No Abstract] [Full Text] [Related]
12. [The long-term remission of rheumatoid arthritis with a single cycle of rituximab].
Glisić B; Knezević B
Vojnosanit Pregl; 2012 Jan; 69(1):78-80. PubMed ID: 22397300
[TBL] [Abstract][Full Text] [Related]
13. [The quality of life in patients with rheumatoid arthritis treated with rituximab].
Mazurov VI; Avlokhova SR
Klin Med (Mosk); 2014; 92(12):42-8. PubMed ID: 25980298
[TBL] [Abstract][Full Text] [Related]
14. Reply: To PMID 23983134.
Bredemeier M
Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1593-6. PubMed ID: 24906046
[No Abstract] [Full Text] [Related]
15. Rituximab effectively reduces macrophage migration inhibitory factor in patients with active rheumatoid arthritis.
Willeke P; Becker H; Schlüter B; Pavenstäd H; Mickholz E; Wierichs C; Gaubitz M; Schotte H
Scand J Rheumatol; 2012 May; 41(3):242-3. PubMed ID: 22401537
[No Abstract] [Full Text] [Related]
16. Campylobacter fetus infection in three rheumatoid arthritis patients treated with rituximab.
Meyer A; Theulin A; Chatelus E; Argemi X; Sordet C; Javier RM; Hansmann Y; Sibilia J; Gottenberg JE
Ann Rheum Dis; 2012 Jun; 71(6):1094-5. PubMed ID: 22302315
[No Abstract] [Full Text] [Related]
17. Rituximab biosimilar CT-P10 for the treatment of rheumatoid arthritis.
Jung JY; Kim JW; Kim HA; Suh CH
Expert Opin Biol Ther; 2019 Oct; 19(10):979-986. PubMed ID: 31498682
[No Abstract] [Full Text] [Related]
18. [Rituximab treatment of rheumatoid arthritis: new evidence].
Nasonov EL
Ter Arkh; 2009; 81(6):82-91. PubMed ID: 19663200
[TBL] [Abstract][Full Text] [Related]
19. [Recommendations on the use of rituximab for patients with rheumatoid arthritis].
Rubbert-Roth A; Burmester G;
Z Rheumatol; 2008 Nov; 67(7):609-13. PubMed ID: 18830700
[No Abstract] [Full Text] [Related]
20. Rituximab therapy for AA-amyloidosis secondary to rheumatoid arthritis.
Narváez J; Hernández MV; Ruiz JM; Vaquero CG; Juanola X; Nollaa JM
Joint Bone Spine; 2011 Jan; 78(1):101-3. PubMed ID: 21067952
[No Abstract] [Full Text] [Related]
[Next] [New Search]
